Marshall Wace North America L.P. - SERES THERAPEUTICS INC ownership

SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 135 filers reported holding SERES THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.

Quarter-by-quarter ownership
Marshall Wace North America L.P. ownership history of SERES THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$598,000
-30.2%
85,755
+106.1%
0.00%
-25.0%
Q1 2021$857,000
-72.6%
41,610
-95.7%
0.00%
-78.9%
Q2 2019$3,133,000
+15565.0%
972,939
+32483.4%
0.02%
Q1 2019$20,0002,9860.00%
Other shareholders
SERES THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 21,571,764$610,696,00016.87%
RA Capital Management 4,750,000$134,473,0002.46%
ARK Investment Management 12,293,033$348,016,0002.06%
Opaleye Management Inc. 335,312$9,493,0001.86%
Sio Capital Management, LLC 316,800$8,969,0001.78%
Ikarian Capital, LLC 762,400$21,585,0001.56%
Nikko Asset Management Americas, Inc. 5,531,670$152,176,0001.35%
EAM Global Investors LLC 121,629$3,443,0001.26%
EAM Investors, LLC 133,591$3,782,0000.90%
GILDER GAGNON HOWE & CO LLC 3,185,420$90,179,0000.56%
View complete list of SERES THERAPEUTICS INC shareholders